US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Argos Therapeutics, Inc.

0.2701

+0.0000

Volume:- -

Turnover:- -

Market Cap:2.14M

PE:-0.02

High:0.2701

Open:0.2701

Low:0.2701

Close:0.2701

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Argos Therapeutics, Inc.

Exchange:

OTCQB

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.argostherapeutics.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases using its ArcelisÃÂÃÂÃÂÃÂ® technology platform. Argos is developing an ArcelisÃÂÃÂÃÂÃÂ®-based product candidate, AGS-004, for the treatment of human immunodeficiency virus (HIV), which is currently being evaluated in an investigator-initiated Phase 2 clinical trial aimed at HIV eradication in adult patients. Funding for the development of AGS-004 has been provided by the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and the Collaboratory of Research for AIDS Eradication.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ARGS/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ARGS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARGS\",,,,,undefined,":{"symbol":"ARGS","market":"US","secType":"STK","nameCN":"Argos Therapeutics, Inc.","latestPrice":0.2701,"timestamp":1533326400000,"preClose":0.2701,"halted":0,"volume":0,"delay":0,"floatShares":6776900,"shares":7909765,"eps":-13.447799,"marketStatus":"Trading","change":0,"latestTime":"04-30 11:56:28 EDT","open":0.2701,"high":0.2701,"low":0.2701,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-13.447799,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.2701,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARGS\",,,,,undefined,":{"symbol":"ARGS","floatShares":6776900,"roa":"--","roe":"--","lyrEps":0,"shares":7909765,"dividePrice":0,"high":0.2701,"amplitude":0,"preClose":0.2701,"low":0.2701,"week52Low":0.2701,"pbRate":"--","week52High":0.2701,"institutionHeld":0,"latestPrice":0.2701,"eps":-13.447799,"divideRate":0,"volume":0,"delay":0,"ttmEps":-13.447799,"open":0.2701},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.argostherapeutics.com","stockEarnings":[{"period":"1week","weight":1.2471},{"period":"1month","weight":1.2471},{"period":"3month","weight":1.2471},{"period":"6month","weight":1.2471},{"period":"1year","weight":1.2471},{"period":"ytd","weight":1.2471}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases using its ArcelisÃÂÃÂÃÂÃÂ® technology platform. Argos is developing an ArcelisÃÂÃÂÃÂÃÂ®-based product candidate, AGS-004, for the treatment of human immunodeficiency virus (HIV), which is currently being evaluated in an investigator-initiated Phase 2 clinical trial aimed at HIV eradication in adult patients. Funding for the development of AGS-004 has been provided by the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and the Collaboratory of Research for AIDS Eradication.","exchange":"OTCQB","name":"Argos Therapeutics, Inc.","nameEN":"Argos Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ARGS\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARGS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-04-02","symbol":"ARGS","name":"Argos Therapeutics, Inc.","time":"","type":"earning","dateTimestamp":1522641600000,"reportTimeType":"","actualEps":-1.05},{"date":"2018-01-19","symbol":"ARGS","type":"split","dateTimestamp":1516338000000,"forFactor":20,"toFactor":1},{"market":"US","date":"2017-11-09","symbol":"ARGS","name":"Argos Therapeutics, Inc.","time":"Post Market","type":"earning","dateTimestamp":1510203600000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2017-08-09","symbol":"ARGS","expectedEps":-0.13,"name":"Argos Therapeutics, Inc.","time":"","type":"earning","dateTimestamp":1502251200000,"reportTimeType":"","actualEps":-0.21},{"market":"US","date":"2017-05-10","symbol":"ARGS","name":"Argos Therapeutics, Inc.","time":"","type":"earning","dateTimestamp":1494388800000,"reportTimeType":"","actualEps":-0.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARGS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARGS\",market:\"US\",delay:false,,,undefined,":{}}}